DURECT Corporation Announces First Quarter 2010 Financial Results MarketWatch (press release) In April 2010, King Pharmaceuticals initiated a Phase IIb trial evaluating the safety and efficacy of ELADUR in patients with chronic low back pain .
Read more from the original source:
DURECT Corporation Announces First Quarter 2010 Financial Results – MarketWatch (press release)
